publication date: Sep. 5, 2014

CPRIT Awards Round of Grants

html CPRIT.html

The Cancer Prevention and Research Institute of Texas last month awarded 101 new grants: 84 for research, 15 for prevention and two for product development.

CPRIT received nearly 600 grant applications, and after review, awarded grants to cancer researchers, prevention initiatives and product development projects from institutions and organizations across the state.

• The research grants added up to $76.2 million, supporting 76 research projects and the recruitment of eight cancer scientists and clinicians to academic institutions in Texas.

• The prevention awards added up to $17.5 million. The projects will support prevention services for underserved populations, focusing on HPV vaccination rates, tobacco cessation in young adult smokers and increasing access to colorectal cancer screening.

• The $13.5 million of two product development grants will support cancer research and development conducted by a Texas-based company and the relocation of an existing cancer-focused company to Texas. The grants will fund projects to develop novel brain cancer treatments and advanced imaging and diagnostic techniques.

With this $107.2 million in grants, CPRIT has given out a total of $970 million in Texas taxpayers’ money. Altogether, the state institution was authorized to spend $3 billion over a decade.

Following a series of scandals in 2012, Texas officials imposed a moratorium on CPRIT’s grant-making. That moratorium was lifted in October 2013, after new members were appointed to the CPRIT oversight committee.

CPRIT, which pays as much in cancer research grants as the federal government within the state, reactivated grant-making in November 2013. The organization has reconstituted its scientific review mechanism after many reviewers resigned in protest over the decision to award … Continue reading 40-33 CPRIT

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.